{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:39:04Z","timestamp":1740166744408,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s13721-020-00267-2","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T19:02:47Z","timestamp":1599850967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improved identification of core biomarkers and drug repositioning for ovarian cancer: an integrated bioinformatics approach"],"prefix":"10.1007","volume":"9","author":[{"given":"Md","family":"Shahjaman","sequence":"first","affiliation":[]},{"given":"Fatema Tuz Zohora","family":"Jui","sequence":"additional","affiliation":[]},{"given":"Tania","family":"Islam","sequence":"additional","affiliation":[]},{"given":"Sukanta","family":"Das","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8739-8714","authenticated-orcid":false,"given":"Md Rezanur","family":"Rahman","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"267_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0074250","volume":"8","author":"R Aguirre-Gamboa","year":"2013","unstructured":"Aguirre-Gamboa R, Gomez-Rueda H, Mart\u00ednez-Ledesma E, Mart\u00ednez-Torteya A, Chacolla-Huaringa R, Rodriguez-Barrientos A, Tamez-Pe\u00f1a JG, Trevi\u00f1o V (2013) SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS ONE 8:1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0074250","journal-title":"PLoS ONE"},{"key":"267_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.pcan.4500848","volume":"9","author":"G Altinok","year":"2006","unstructured":"Altinok G, Powell IJ, Che M, Hormont K, Sarkar FH, Sakr WA, Grignon D, Liao DJ (2006) Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma. Prostate Cancer Prostatic Dis 9:77\u201382","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"267_CR3","first-page":"31","volume":"27","author":"MI Asifuzzaman","year":"2019","unstructured":"Asifuzzaman MI, Akter H, Rashid MM, Mollah MNH, Islam SMS, Shahjaman M (2019) Improved k-nearest neighbors approach for incomplete and contaminated gene expression datasets. J Biosci 27:31\u201341","journal-title":"J Biosci"},{"key":"267_CR4","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M (2012) NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res 41:D991\u2013D995","journal-title":"Nucleic Acids Res"},{"key":"267_CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289\u2013300","journal-title":"J R Stat Soc Ser B"},{"key":"267_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejps.2012.12.003","volume":"48","author":"DP Bezerra","year":"2013","unstructured":"Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER, Costa-Lotufo LV (2013) Overview of the therapeutic potential of piplartine (piperlongumine). Eur J Pharm Sci 48:453\u2013463","journal-title":"Eur J Pharm Sci"},{"key":"267_CR7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/onc.2014.72","volume":"34","author":"U Bharadwaj","year":"2015","unstructured":"Bharadwaj U, Eckols TK, Kolosov M, Kasembeli MM, Adam A, Torres D, Zhang X, Dobrolecki LE, Wei W, Lewis MT (2015) Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene 34:1341\u20131353","journal-title":"Oncogene"},{"key":"267_CR8","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/ijc.30676","volume":"140","author":"SB Coburn","year":"2017","unstructured":"Coburn SB, Bray F, Sherman ME, Trabert B (2017) International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J cancer 140:2451\u20132460","journal-title":"Int J cancer"},{"key":"267_CR9","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J cancer 127:2893\u20132917","journal-title":"Int J cancer"},{"key":"267_CR10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/omi.2017.0115","volume":"21","author":"E Gov","year":"2017","unstructured":"Gov E, Kori M, Arga KY (2017) Multiomics analysis of tumor microenvironment reveals Gata2 and miRNA-124-3p as potential novel biomarkers in ovarian cancer. OMICS 21:603\u2013615","journal-title":"OMICS"},{"key":"267_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrd2227","volume":"6","author":"S Grant","year":"2007","unstructured":"Grant S, Easley C, Kirkpatrick P (2007) Vorinostat. Nat Rev Drug Discov 6:21\u201322. https:\/\/doi.org\/10.1038\/nrd2227","journal-title":"Nat Rev Drug Discov"},{"key":"267_CR12","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/ijc.25151","volume":"127","author":"A Hayashi","year":"2010","unstructured":"Hayashi A, Horiuchi A, Kikuchi N, Hayashi T, Fuseya C, Suzuki A, Konishi I, Shiozawa T (2010) Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin. Int J cancer 127:1332\u20131346","journal-title":"Int J cancer"},{"key":"267_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3329\/akmmcj.v8i2.33675","volume":"8","author":"ME Hoque","year":"2017","unstructured":"Hoque ME, Karim S, Siddiqui MMR, Ahmed T (2017) Report on three cases of advance ovarian cancer upon Bangladeshi population: successful management with bevacizumab based chemotherapy. Anwer Khan Mod Med Coll J 8:157\u2013161","journal-title":"Anwer Khan Mod Med Coll J"},{"key":"267_CR14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/neu.2008.0835","volume":"26","author":"W Huang","year":"2009","unstructured":"Huang W, Bhavsar A, Ward RE, Hall JCE, Priestley JV, Michael-Titus AT (2009) Arachidonyl trifluoromethyl ketone is neuroprotective after spinal cord injury. J Neurotrauma 26:1429\u20131434","journal-title":"J Neurotrauma"},{"key":"267_CR15","doi-asserted-by":"crossref","first-page":"100250","DOI":"10.1016\/j.imu.2019.100250","volume":"17","author":"T Islam","year":"2019","unstructured":"Islam T, Rahman MR, Shuvo MAH, Shahjaman M, Islam MR, Karim MR (2019) Drug repositioning and biomarkers in low-grade glioma via bioinformatics approach. Informatics Med Unlocked 17:100250","journal-title":"Informatics Med Unlocked"},{"key":"267_CR16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ijc.28011","volume":"133","author":"EM Je","year":"2013","unstructured":"Je EM, Yoo NJ, Kim YJ, Kim MS, Lee SH (2013) Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors. Int J cancer 133:260\u2013265","journal-title":"Int J cancer"},{"key":"267_CR17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7150\/jca.8731","volume":"5","author":"A Jurczyszyn","year":"2014","unstructured":"Jurczyszyn A, Zebzda A, Czepiel J, Perucki W, Bazan-Socha S, Cibor D, Owczarek D, Majka M (2014) Geldanamycin and its derivatives inhibit the growth of myeloma cells and reduce the expression of the MET receptor. J Cancer 5:480","journal-title":"J Cancer"},{"key":"267_CR18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","volume":"386","author":"S Kehoe","year":"2015","unstructured":"Kehoe S, Hook J, Nankivell M, Jayson GC, Kitchener H, Lopes T, Luesley D, Perren T, Bannoo S, Mascarenhas M (2015) Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet 386:249\u2013257","journal-title":"Lancet"},{"key":"267_CR19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","volume":"47","author":"WH Kruskal","year":"1952","unstructured":"Kruskal WH, Wallis WA (1952) Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47:583\u2013621","journal-title":"J Am Stat Assoc"},{"key":"267_CR20","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2019-1739","author":"CC Lepage","year":"2019","unstructured":"Lepage CC, Nachtigal MW, McManus KJ (2019) Diminished SKP1 or CUL1 expression induces chromosome instability in high-grade serous ovarian cancer precursor cells. Am Assoc Cancer Res. https:\/\/doi.org\/10.1158\/1538-7445.AM2019-1739","journal-title":"Am Assoc Cancer Res"},{"key":"267_CR21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1158\/1541-7786.MCR-08-0255","volume":"7","author":"N Matsumura","year":"2009","unstructured":"Matsumura N, Huang Z, Baba T, Lee PS, Barnett JC, Mori S, Chang JT, Kuo W-L, Gusberg AH, Whitaker RS (2009) Yin yang 1 modulates taxane response in epithelial ovarian cancer. Mol Cancer Res 7:210\u2013220","journal-title":"Mol Cancer Res"},{"key":"267_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0168-9525(02)02665-3","volume":"18","author":"R Nadon","year":"2002","unstructured":"Nadon R, Shoemaker J (2002) Statistical issues with microarrays: processing and analysis. TRENDS Genet 18:265\u2013271","journal-title":"TRENDS Genet"},{"key":"267_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55010020","author":"MR Rahman","year":"2019","unstructured":"Rahman MR, Islam T, Gov E, Turanli B, Gulfidan G, Shahjaman M, Banu NA, Mollah MNH, Arga KY, Moni MA (2019) Identification of prognostic biomarker signatures and candidate drugs in colorectal cancer: insights from systems biology analysis. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina55010020","journal-title":"Medicina (Kaunas)"},{"key":"267_CR24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.maturitas.2013.11.009","volume":"77","author":"BC Schmid","year":"2014","unstructured":"Schmid BC, Oehler MK (2014) New perspectives in ovarian cancer treatment. Maturitas 77:128\u2013136","journal-title":"Maturitas"},{"key":"267_CR25","doi-asserted-by":"publisher","first-page":"5310198","DOI":"10.1155\/2017\/5310198","volume":"2017","author":"M Shahjaman","year":"2017","unstructured":"Shahjaman M, Kumar N, Mollah M, Hossain M, Ahmed M, Ara Begum A, Haque N (2017) Robust significance analysis of microarrays by minimum \u03b2-divergence method. BioMed Res Int 2017:5310198. https:\/\/doi.org\/10.1155\/2017\/5310198","journal-title":"BioMed Res Int"},{"key":"267_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55060269","author":"M Shahjaman","year":"2019","unstructured":"Shahjaman M, Rahman MR, Islam SMS, Mollah MNH (2019) A robust approach for identification of cancer biomarkers and candidate drugs. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina55060269","journal-title":"Medicina (Kaunas)"},{"key":"267_CR27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12035-014-8986-0","volume":"53","author":"A Shao","year":"2016","unstructured":"Shao A, Wang Z, Wu H, Dong X, Li Y, Tu S, Tang J, Zhao M, Zhang J, Hong Y (2016) Enhancement of autophagy by histone deacetylase inhibitor trichostatin a ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats. Mol Neurobiol 53:18\u201327","journal-title":"Mol Neurobiol"},{"key":"267_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"267_CR29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40618-018-0919-8","volume":"42","author":"J Sim\u00f5es-Pereira","year":"2019","unstructured":"Sim\u00f5es-Pereira J, Moura MM, Marques IJ, Rito M, Cabrera RA, Leite V, Cavaco BM (2019) The role of EIF1AX in thyroid cancer tumourigenesis and progression. J Endocrinol Invest 42:313\u2013318","journal-title":"J Endocrinol Invest"},{"key":"267_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:1\u201325. https:\/\/doi.org\/10.2202\/1544-6115.1027","journal-title":"Stat Appl Genet Mol Biol"},{"key":"267_CR31","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, Gould J, Davis JF, Tubelli AA, Asiedu JK, Lahr DL, Hirschman JE, Liu Z, Donahue M, Julian B, Khan M, Wadden D, Smith IC, Lam D, Liberzon A, Toder C, Bagul M, Orzechowski M, Enache OM, Piccioni F, Johnson SA, Lyons NJ, Berger AH, Shamji AF, Brooks AN, Vrcic A, Flynn C, Rosains J, Takeda DY, Hu R, Davison D, Lamb J, Ardlie K, Hogstrom L, Greenside P, Gray NS, Clemons PA, Silver S, Wu X, Zhao W-N, Read-Button W, Wu X, Haggarty SJ, Ronco LV, Boehm JS, Schreiber SL, Doench JG, Bittker JA, Root DE, Wong B, Golub TR (2017) A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell 171:1437\u20131452.e17. https:\/\/doi.org\/10.1016\/j.cell.2017.10.049","journal-title":"Cell"},{"key":"267_CR32","first-page":"13","volume":"1","author":"W Sumanasekera","year":"2018","unstructured":"Sumanasekera W, Beckmann T, Fuller L, Castle M, Huff M (2018) Epidemiology of ovarian cancer: risk factors and prevention. Biomed J 1:13","journal-title":"Biomed J"},{"key":"267_CR33","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP (2015) STRING v10: protein\u2013protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43:D447\u2013D452","journal-title":"Nucleic Acids Res"},{"key":"267_CR34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL (2018) Ovarian cancer statistics, 2018. CA Cancer J Clin 68:284\u2013296","journal-title":"CA Cancer J Clin"},{"key":"267_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fgene.2019.00420","volume":"10","author":"B Turanli","year":"2019","unstructured":"Turanli B, Karagoz K, Bidkhori G, Sinha R, Gatza ML, Uhlen M, Mardinoglu A, Arga KY (2019a) Multi-omic data interpretation to repurpose subtype specific drug candidates for breast cancer. Front Genet 10:420. https:\/\/doi.org\/10.3389\/fgene.2019.00420","journal-title":"Front Genet"},{"key":"267_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ebiom.2019.03.009","volume":"42","author":"B Turanli","year":"2019","unstructured":"Turanli B, Zhang C, Kim W, Benfeitas R, Uhlen M, Arga KY, Mardinoglu A (2019b) Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning. EBioMedicine 42:386\u2013396. https:\/\/doi.org\/10.1016\/j.ebiom.2019.03.009","journal-title":"EBioMedicine"},{"key":"267_CR37","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci 98:5116\u20135121","journal-title":"Proc Natl Acad Sci"},{"key":"267_CR38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7314\/APJCP.2014.15.1.191","volume":"15","author":"B Wang","year":"2014","unstructured":"Wang B, Liu S-Z, Zheng R-S, Zhang F, Chen W-Q, Sun X-B (2014) Time trends of ovarian cancer incidence in China. Asian Pacific J cancer Prev 15:191\u2013193","journal-title":"Asian Pacific J cancer Prev"},{"key":"267_CR39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3892\/ol.2015.3996","volume":"11","author":"L Wang","year":"2016","unstructured":"Wang L, Li L, Yang Z (2016) Correlation of FOXC1 protein with clinicopathological features in serous ovarian tumors. Oncol Lett 11:933\u2013938","journal-title":"Oncol Lett"},{"issue":"6","key":"267_CR40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/3001968","volume":"1","author":"F Wilcoxon","year":"1945","unstructured":"Wilcoxon F (1945) Individual comparisons by ranking methods. Biom Bull 1(6):80\u201383","journal-title":"Biom Bull"},{"key":"267_CR41","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nprot.2015.052","volume":"10","author":"J Xia","year":"2015","unstructured":"Xia J, Gill EE, Hancock REW (2015) NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat Protoc 10:823","journal-title":"Nat Protoc"},{"key":"267_CR42","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.2147\/OTT.S146228","volume":"11","author":"W Xiang","year":"2018","unstructured":"Xiang W, Yang C-Y, Bai L (2018) MCL-1 inhibition in cancer treatment. Onco Targets Ther 11:7301","journal-title":"Onco Targets Ther"},{"key":"267_CR43","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.7150\/jca.30235","volume":"10","author":"L Yu","year":"2019","unstructured":"Yu L, Li J-J, Liang X-L, Wu H, Liang Z (2019) PSME3 promotes TGFB1 secretion by pancreatic cancer cells to induce pancreatic stellate cell proliferation. J Cancer 10:2128","journal-title":"J Cancer"},{"key":"267_CR44","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s13277-015-4770-7","volume":"37","author":"L Zhan","year":"2016","unstructured":"Zhan L, Zhang Y, Wang W, Song E, Fan Y, Wei B (2016) E2F1: a promising regulator in ovarian carcinoma. Tumor Biol 37:2823\u20132831","journal-title":"Tumor Biol"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-020-00267-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-020-00267-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-020-00267-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T17:52:53Z","timestamp":1723571573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-020-00267-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1007\/s13721-020-00267-2","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"type":"print","value":"2192-6662"},{"type":"electronic","value":"2192-6670"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"30 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"62"}}